BTIG Reiterates Buy on Verastem, Maintains $18 Price Target

BTIG analyst Jeet Mukherjee has reiterated a Buy rating on Verastem (NASDAQ: VSTM) and maintained a price target of $18. This endorsement suggests continued confidence in the company's performance and potential for growth.